Bibliography
8.1 Headache induced by acute substance use or exposure
Altura BM, Altura BT, Gebrewold A.
Alcohol induced spasm of cerebral blood vessels. J Mental Sci 2000;104:972-999.
Armstrong, P.J. and A. Bersten (1986).
Normeperidine toxicity. Anesth Analg 65:536-538.
Ashina M, Bendtsen L, Jensen R, Olesen J.
Nitric oxide-induced headache in patients with chronic tension-type headache. Brain 2000; 123: 1830-1837.
Bouillabaisse: an outbreak of methemoglobinemia in New Jersey in 1992.
Pediatrics 94:381-384.
Askmark H, Lundberg PO, Olsson S.
Drug related headache. Headache 1989; 29:441-444.Atkins, F.M. (1986). A critical evaluation of clinical trials in adverse reactions to foods in adults. J Allergy Clin Immunol 78:174-182.
Beck, H.G., W.H. Schulze, and G.M. Suter (1940).
Carbon monoxide-a domestic hazard. JAMA 115:1.
Bonnet, G.F. and P. Nepveux (1971).
Migraine due to tyramine. Sem Hop 47:2441-2445.
Brewerton, T.D., D.L. Murphy, M.D. Lesem, H.A. Brandt, and D.C. Jimerson (1992).
Headache responses following m-chlorophenylpiperazine in bulimics and controls. Headache 32:217-22.
Catalano, G., M.C. Catalano, and R. Rodriguez (1997).
Dystonia associated with crack cocaine use. South Med J 90:1050-1052.
Cleophas, T.J., M.G. Niemeyer, E.E. vanderWall, and J. vanderMeulen (1996).
Nitrate-induced headache in patients with stable angina pectoris: beneficial effect of starting on a low dose. Angiology 47:679-685.
Council of Scientific Affairs (1985).
Aspartame: review of safety issues. JAMA 254:400-402.
Cregler, L.L. and H. Mark (1986).
Medical complications of cocaine abuse. N Engl J Med 315:1495-1501.
Dalton K (1976).
Migraine and oral contraceptives. Headache 15: 247-251.
Dhopesh, V., I. Maany, and C. Herring (1991).
The relationship of cocaine to headache in polysubstance abusers. Headache 31:17-19.
Dhuna, A., A. Pascual-Leone, and M. Belgrade.
Cocaine-related vascular headaches. J Neurol Neurosurg Psychiat 1991;54:803-6.
De Marinis M, Janiri L, Agnoli A.
Headache in the use and withdrawal of opiates and other associated substances of abuse. Headache 1991; 31: 159-163.
Ekbom, K. (1968).
Nitroglycerin as a provocative agent in cluster headache. Arch Neurol 19:487-493.
el-Mallakh, R.S. (1987).
Marijuana and migraine. Headache 27:442-443.
el-Mallakh, R.S., H.R. Kranzler, and J.R. Kamanitz (1991).
Headaches and psychoactive substance use. Headache 31:584-587.
Forbes, H.S., S. Cobb, and F. Fremont-smith (1924).
Cerebral edema and headache following carbon monoxide asphyxia. Arch Neurol Psychiatr 11:164.
Gawin, F.H. (1991).
Cocaine addiction: psychology and neurophysiology. Science 251:1580-1586.
Ghose, K. and J.D. Carrol (1984).
Mechanisms of tyramine-induced migraine: similarities with dopamine and interactions with disulfiram and propranolol. Neuropsychiobiol 12:122-126.
Gordon, C.R., D. Mankuta, A. Shupak, O. Spitzer, and I. Doweck (1991).
Recurrent classic migraine attacks following transdermal scopolamine intoxication. Headache 31:172-174.
Gore ME, Salmon PR.
Chinese restaurant syndrome: fact or fiction. Lancet 1980;318:251-2.
Hanington, E. and A.M. Harper (1968).
The role of tyramine in the etiology of migraine and related studies on the cerebral and intracerebral circulations. Headache 8:84-97.
Hansen, H.J. and V.M. Drewes (1970).
The nitroglycerine ointment test-a double-blind examination. Dan Med Bull 17:226-229.
Heckerling, P.S., J.B. Leikin, A. Maturen, and J.T. Perkins (1987).
Predictors of occult carbon monoxide poisoning in patients with headache and dizziness. Ann Int Med 107:174-176.
Henderson, W.R. and N.H. Raskin (1972).
"Hot dog" headache: individual susceptibility to nitrite. Lancet 2:1162-1163.
Hirsch, A.R., K.M. Rankin, and P.P. Panelli (1996).
Trichloroethylene exposure and headache. Headache Quarterly 7:126-138.
Horowitz, L.D., M.V. Herman, and R. Gorlin (1972).
Clinical response to nitroglycerine as a diagnostic test for coronary artery disease. Am J Cardiol 29:149-153.
Iversen HK, Nielsen TM, Olesen J, Tfelt-Hansen P (1989).
Intravenous nitroglycerin as an experimental model of vascular headache. Basic characteristics. Pain 38: 17-24.
Kenney, R.A. and C.S. Tidball (1972).
Human susceptibility to oral monosodium 1-glutamate. Am J Clin Nutr 25:140-146.
Kerr, G.R., M.W. Lee, M. elLozy, R. McGandy, and F. Stare (1979).
Prevalence of the "Chinese restaurant syndrome". J Am Diet Assoc 75:29-33.
Krabbe, A.A. and J. Olesen (1980).
Headache provocation by continuous intravenous infusion of histamine, clinical results and receptor mechanisms. Pain 8:253-259.
Larkin, J.M., G.J. Brahos, and J.A. Moylin (1976).
Treatment of carbon monoxide poisoning: prognostic factors. J Trauma 16:111.
Lassen LH, Thomsen LL, Olesen J (1995).
Histamine induces migraine via the H receptor. Support for the NO-hypothesis of migraine. Neuroreport 6: 1475-1479.
Leon, A.S., D.B. Hunninghake, C. Bell, D.K. Rassin, and T.R. Tephly (1989).
Safety of long-term doses of aspartame. Arch Int Med 149:2318-2324.
Leone, M., A. Attanasio, D. Croci, G. Filippini, D. D'Amico, L. Grazzi, A. Nespolo, and G. Bussone (2000).
The serotonergic agent m-chlorophenylpiperazine induced migraine attacks: a controlled study. Neurology 55:136-139.
Levine, S.R., J.C. Brust, N. Futrell, and et al. (1990).
Cerebrovascular complications of the use of the crack form of alkaloidal cocaine. N Engl J Med 323:699-704.
Lipton, R.B., C.M. Kwong, and S. Solomon.
Headaches in hospitalized cocaine users. Headache 1989;29:225-8.
Lowenstein, D.H., S.M. Massa, M.C. Rowbotham, and et al. (1987).
Acute neurologic and psychiatric complications associated with cocaine abuse. Am J Med 83:841-846.
Luthy, J. and C. Schlatter (1983).
Biogenic amines in food: effects of histamine, tyramine and phenylethylamine in the human. Z Lebensm Unters Forsch 177:439-443.
Magos AL, E Brewster, R Singh T O'Dowd, M Brincat, JWW Studd (1986).
The effects of norethisterone in postmenopausal women on oestrogen replacement therapy: a model for the premenstrual syndrome. Br J Obstet Gynaecol 93: 1290-1296.
McCullock, J. and A.M. Harper (1978).
Phenylethylamine and the cerebral circulation. In Current concepts in migraine research, (J. McCullock and A.M. Harper, eds.) pp. 85-88. Raven Press, New York.
Meigs, J.L. and J.P. Hughes (1952).
Acute carbon monoxide poisoning: an analysis of 105 cases. AMA Arch Ind Hygiene Occupat Med 6:344-356.
Merkel, P.A., W.J. Koroshetz, M.C. Irizarry, and M.E. Cudkovicz (1995).
Cocaine-associated cerebral vasculitis. Semin Arthritis Rheum 25:172-183.
Merrit, J.E. and P.B. Williams (1990).
Vasospasm contributes to monosodium glutamate-induced headache. Headache 30:575-580.
Mitchell, J.D. (1995).
Clinical neurotoxicology: In Handbook of clinical neurology, (F.A. DeWolff, ed.) pp. 1-22. Elsevier Science,
Moffet, A.M., M. Swash, and D.F. Scott (1974).
Effect of chocolate in migraine: a double-blind study. J Neurol Neurosurg Psychiatry 37:445-448.
Monteiro, J.M. (1993).
Headache associated with single use of substances. In The headaches, (J. Olesen, P. Tfelt-Hansen, and K.M.A. Welch, eds.) pp. 715-720. Raven Press, Limited, New York.
Monteiro, J.M. and C.G. Dahlof (2000).
Single use of substances. In The Headaches, (J. Olesen, P. Tfelt-Hansen, and K.M. Welch, eds.) pp. 861-869. Lippincott Williams & Wilkins, Philadelphia.
Murphree, A.B., L.A. Greenberg, and R.B. Carrol (1967).
Neuropharmacologic effects of substances other than ethanol in alcoholic beverages. Fed Proc 26:1468-1473.
Nappi RE, A Cagnacci, F Granella, F Piccinini, F Polatti, F Facchinetti (2001).
Course of primary headaches during hormone replacement therapy. Maturitas 38: 157-63.
Norton, S. (1975).
Toxicology of the central nervous system. In Toxicology, (L.J. Casarett and J. Doult, eds.) pp. 1019-1035. MacMillan, New York.
Ogata S, Hosoi T, Saji H.
Studies on acute alcohol intoxication. Japanese Journal of Studies of Alcohol 1966; 1: 67-79.
Peters, G.A. (1953).
Migraine: diagnosis and treatment with emphasis on the migraine-tension headache, provocative tests and use of rectal suppositories. Proc Mayo Clin 28:673-686.
Reif-Lehrer, L. (1977).
A questionnaire study of the prevalence of Chinese restaurant syndrome. Fed Proc 36:1617-1623.
Sabatini, U., O. Rascol, A. Rascol, and J.L. Montastruc (1990).
Migraine attacks induced by subcutaneous apomorphine in two migrainous Parkinson Ian patients. Clin Neuropharmacol 13:264-267.
Satel, S.L. and F.H. Gawin (1989).
Migraine-like headache and cocaine use. JAMA 261:2995-2996.
Schamburg, H.H., R. Byck, R. Gerstl, and J.H. Mashman (1969).
Monosodium L-glutamate: its pharmacology and role in the Chinese restaurant syndrome. Science 163:826-828.
Scher, W. and B.M. Scher (1992).
A possible role for nitric oxide in glutamate (MSG)-induced Chinese restaurant syndrome, glutamate induced asthma, "hot-dog headache", pugilistic Alzheimer's disease, and other disorders. Med Hypotheses 38:185-188.
Schiffmann, S.S., C.E. Buckley, H.A. Sampson, and et al. (1987).
Aspartame and susceptibility to headache. N Engl J Med 317:1181-1185.
Schnitker, M.T. and M.A. Schnitker (1947).
Clinical notes, suggestions and new instruments. J Amer Med Assoc 135:89
Schwartz, A.M. (1946).
The cause, relief and prevention of headache arising from contact with dynamite. N Engl J Med 235:541-544.
Scopp, A.L. (1991).
MSG and hydrolyzed vegetable protein induced headache review and case studies. Headache 31:107-110.
Seltzer, S. (1982).
Foods and drug combinations, responsible for head and neck pain. Cephalalgia 2:111-124.
Shaw, S.W., R.H. Johnson, and H.G. Keogh (1978).
Oral tyramine in dietary migraine sufferers. In Current concepts in migraine research, (S.W. Shaw, R.H. Johnson, and H.G. Keogh, eds.) pp. 31-39. Raven Press, New York.
Shively, M. and B. Riegel (1991).
Effect of nitroglycerin ointment placement on headache and flushing in health subjects. Int J Nurs Stud 28:153-161.
Sicuteri, F., E.D. Bene, M. Poggioni, and A. Bonazzi (1987).
Unmasking latent dysnociception in healthy subjects. Headache 27:180-185.
Smith, I., A.H. Kellow, and E. Hanington (1970).
Clinical and biochemical correlation between tyramine and migraine headache. Headache 10:43-52.
Tarasoff, L. and M.F. Kelly (1993).
Monosodium L-glutamate: a double-blind study and review. Food Chem Toxicol 31:1019-1035.
Thomsen LL, Kruse C, Iversen HK, Olesen J.
A Nitric oxide donor triggers genuine migraine attacks. Eur J Neurol 1994; 1: 71-80.
Towers, C.V., R.A. Pircon, M.P. Nageotte, M. Porto, and T.J. Garite (1993).
Cocaine intoxication presenting as preeclampsia and eclampsia. Ob Gyn 81:545-547.
Trelles, L. and R. Jeri.
Central nervous system stimulants: cocaine, amphetamine, nicotine. In Handbook of clinical neurology, (F.A. DeWolff, ed.). New York: Elsevier Science, 1995: 251-7.
Wallgreen H, Barry A.
Drug actions in relation to alcohol effects. In: Action of alcohol. New York: Elsevier, 1970:621-714.
Wilson, J. (1995).
Cyanogenic glycosides. Ch. 3 in Handbook of clinical neurology, vol. 65 (F.A. DeWolff, ed.). New York: Elsevier Science, 1995: 25-34.
Varon J, Marik PE, Fromm RE, Gueler A.
Carbon Monoxide Poisoning: a review for clinicians. J. Emerg Med 1999; 17:87-93.
Yang, W.H., M.A. Drouin, M. Herbert, Y. Mao, and J. Kursh (1997).
The monosodium glutamate symptom complex: assessment in a double blind, placebo controlled, randomized study. J Allergy Clin Immunol 99:757-762.
8.2 Medication-overuse headache
Ala-Hurula, V., V. Myllyla, and E. Hokkanen (1982).
Ergotamine abuse: results of ergotamine discontinuation with special reference to the plasma concentrations. Cephalalgia 2:189-195.
Ala-Hurula, V., V. Myllyla, E. Hokkanen, and O. Tokola (1981).
Tolfenamic acid and ergotamine abuse. Headache 21:240-242.
Allgulander, C. (1986).
History and current status of sedative-hypnotic drug use and abuse. Acta Psychiatr Scand 73:465-478.
Andersson, P.G. (1975).
Ergotamine headache. Headache 15:118-121.
Baar, H.A. (1990).
Treatment for headache: a four-step standardized withdrawal program for analgesic abusers. Pain Clin 3:173-177. (Abstract).
Bennett, W.M. and M.E. DeBroe (1989).
Analgesic nephropathy: a preventable renal disease. N Eng J Med 320:1269-1271.
Bowdler, I., J. Killian, and S. Gänsslen-Blumberg.
The association between analgesic abuse and headache--coincidental or causal. Headache 1988;28:494.
Braithwaite RA.
The toxicity of tricyclic and newer antidepressants. In Handbook of Clinical Neurology, (F.A. DeWolff, ed.) pp. 311-320. New York: Elsevier Science 1995:311-20.
Brust, J.C. (1995).
Opiate addiction and toxicity. Ch. 16 in Handbook of clinical neurology, vol. 65 (F.A. DeWolff, ed.). New York: Elsevier Science: 356-361.
Catarci, T., F. Fiacco, and C. Argentino (1994).
Ergotamine-induced headache can be sustained by sumatriptan daily intake. Cephalalgia 14:374-375.
Centonze, V., B.M. Polite, M. diBari, P. Caporaletti, and O. Albano (1993).
Vascular injuries in ergotamine abuse: a case report. Funct Neurol 8:265-270.
Dalquen, P., J. Fasel, M.J. Mihatsch, M. Rist, and G. Rutishauser (1980).
Phenacetinabusus IV. Sind zytologische harnuntersuchungen in der tumorvorsorge bei phenacetinabusern erfolgversprechend und anwendbar. Schweizerische Medizinische Wochenschrift 110:302-306.
DeBroe, M.E. and M.M. Elseviers (1993).
Analgesic nephropathy--still a problem? Nephron 64:505-513.
deMarinis, M., L. Janiri, and A. Agnoli (1991).
Headache in the use and withdrawal of opiates and other associated substances of abuse. Headache 31:159-163.
Diamond, S. and D.J. Dalessio (1982).
Drug abuse in headache. In The practicing physician's approach to headache, (S. Diamond and D.J. Dalessio, eds.) pp. 114-121. Williams & Wilkins, Baltimore.
Dichgans, J. and H.C. Diener (1988).
Clinical manifestations of excessive use of analgesic medication. In Drug-induced headache, (H.C. Diener and M. Wilkinson, eds.) pp. 8-15. Springer-Verlag, Berlin.
Dichgans, J., H.D. Diener, W.D. Gerber, and et al. (1984).
Analgetika-induzierter dauerkopfschmerz. Dtsch Med Wschr 109:369-73.
Diener, H.C. (1993).
A personal view of the classification and definition of drug dependence headache. Cephalalgia 13:68-71.
Diener, H.C. and C.G. Dahlof (1999).
Headache associated with chronic use of substances. In The headaches, (J. Olesen, P. Tfelt-Hansen, and K.M.A. Welch, eds.) pp. 871-878. Lippincott, Williams & Wilkins, Philadelphia.
Diener, H.C., J. Dichgans, E. Scholz, S. Geiselhart, W.D. Gerber, and A. Bille (1989).
Analgesic-induced chronic headache: long-term results of withdrawal therapy. J Neurol 236:9-14.
Diener, H.C., J. Haab, C. Peters, S. Ried, J. Dichgans, and A. Pilgrim (1991).
Subcutaneous sumatriptan in the treatment of headache during withdrawal from drug-induced headache. Headache 31:205-209.
Diener, H.C., V. Pfaffenrath, D. Soyka, and W.D. Gerber (1992).
Therapie des medikamenten-induzierten dauerkopfschmerzes. Münch Med Wschr 134:159-162.
Diener, H.C. and P. Tfelt-Hansen (1993).
Headache associated with chronic use of substances. In The headaches, (J. Olesen, P. Tfelt-Hansen, and K.M.A. Welch, eds.) pp. 721-727. Raven press LTD, New York.
Dige-Petersen, H., N.A. Lassen, J. Noer, K.H. Toennesen, and J. Olesen (1977).
Subclinical ergotism. Lancet i:65-66.
Drucker, P. and S. Tepper (1998).
Daily sumatriptan for detoxification from rebound. Headache 38:687-690.
Dubach, U.C., B. Rosner, and E. Pfister (1983).
Epidemiologic study of abuse of analgesics containing phenacetin. Renal morbidity and mortality (1968-1979). N Engl J Med 308:357-362.
Elkind, A.H. (1989).
Drug abuse in headache patients. Clin J Pain 5:111-120.
Elkind, A.H. (1991).
Drug abuse and headache. Med Clin N Am 75:717-732.
Evers, S., I. Gralow, B. Bauer, B. Suhr, A. Buchheister, I.W. Husstedt, and E.B. Ringelstein (1999).
Sumatriptan and ergotamine overuse and drug-induced headache: a clinicoepidemiologic study. Clin Neuropharmacol 22:201-206.
Fanciullaci, M., M. Alessandri, U. Pietrini, E. Briccolani-Bandini, and S. Beatrice (1992).
Long-term ergotamine abuse: effect on adrenergically induced mydriasis. Clin Pharm Ther 51:302-307.
Fincham, J.E. (1987).
Over-the-counter drug use and misuse by the ambulatory elderly: a review of the literature. J Ger Drug Ther;1:3-21.
Fincham, R.W., Z. Perdue, and V.D. Dunn (1985).
Bilateral focal cortical atrophy and chronic ergotamine abuse. Neurology 35:720-722.
Fisher, C.M. (1988).
Analgesic rebound headache refuted. Headache 28:666.
Friedman, A.P., P. Brazil, and T.J. vonStorch (1955).
Ergotamine tolerance in patients with migraine. JAMA 157:881-884.
Gaist, D., J. Hallas, S.H. Sindrup, and L.F. Gram (1996).
Is overuse of sumatriptan a problem? A population-based study. Eur J Clin Pharmacol 50:161-165.
Gaist, D., I. Tsiropoulus, S.H. Sindrup, J. Hallas, B.K. Rasmussen, and J. Kragstrup (1998).
Inappropriate use of sumatriptan: population based register and interview study. Br J Med 316:1352-1353.
Granella, F., S. Farina, G. Malferrari, and G.C. Manzoni (1987).
Drug abuse in chronic headache: a clinicoepidemiologic study. Cephalalgia 7:15-19.
Gutzwiller, F. and E. Zemp (1986).
Der analgetikakonsum in der bevölkerung und socioökonomische aspekte des analgetikaabusus. In Das analgetikasyndrom, (M.J. Mihatsch, ed. ) pp. 197-205. Thieme, Stuttgart.
Hering, R. and T.J. Steiner (1991).
Abrupt outpatient withdrawal from medication in analgesic-abusing migraineurs. Lancet 337:1442-1443.
Hokkanen, E., O. Waltimo, and T. Kallanranta (1978).
Toxic effects of ergotamine used for migraine. Headache 18:95-98.
Horowski, R. and A. Ziegler (1988).
Possible pharmacological mechanisms of chronic abuse of analgesics and other antimigraine drugs. In Drug-induced headache, (H.C. Diener and M. Wilkinson, eds. ) pp. 95-104. Springer-Verlag, Berlin.
Horton, B.T. and G.A. Peters (1963).
Clinical manifestations of excessive use of ergotamine preparations and management of withdrawal effect: report of 52 cases. Headache 3:214-226.
Isler, H. (1982).
Migraine treatment as a cause of chronic migraine. In Advances in migraine research and therapy, (F.C. Rose, ed.) pp. 159-164. Raven Press, New York.
Jaffe, J.H. (1985).
Drug addiction and drug abuse. In The pharmacological basis of therapeutics, (A.G. Gilman, T.W. Rall, A.S. Nies, and P. Taylor, eds. ) pp. 522-573. Pergamon Press, New York.
Katsarava Z, Fritsche G, Muessig M, Diener HC, Limmroth V.
Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology. 2001;57:1694-1698.
Kaube, H., A. May, H.C. Diener, and V. Pfaffenrath (1994).
Sumatriptan misuse in daily chronic headache. Br Med J 308:1573.
Kielholz, P. and D. Ladewig (1981).
Probleme des medikamentenmi beta-brauches. Schweiz Ärztezeitung 62:2866-2869.
Klapper, J.A. (1992).
Rebound headache: definition, symptomatology, treatment, and prevention. Headache Quarterly 3:398-402.
Kouyanou, K., C.E. Pither, S. Rabe-Hesketh, and S. Wessely (1998).
A comparative study of iatrogenesis, medication abuse, and psychiatric morbidity in chronic pain patients with and without medically explained symptoms. Pain 76:417-426.
Kudrow, L. (1982).
Paradoxical effects of frequent analgesic use. Adv Neurol 33:335-341.
Lader M.
Hypnotics and sedatives. In Handbook of clinical neurology, (F.A. DeWolff, ed.). New York: Elsevier Science 1995: 329-55.
Lance, F., C. Parkes, and M. Wilkinson (1988).
Does analgesic abuse cause headache de novo? Headache 61-62.
Lance, J.W. (1990).
A concept of migraine and the search for the ideal headache drug. Headache 30:17-23.
Limmroth, V., S. Kazarawa, G. Fritsche, and H.C. Diener (1999).
Headache after frequent use of new 5-HT agonists zolmitriptan and naratriptan. Lancet 353:378.
Limmroth V, Katsarava Z, Fritsche G, Przywara S, Diener HC.
Features of medication overuse headache following overuse of different acute headache drugs. Neurology 2002;59:1011-1014.
Lucas, R.N. and W. Falkowski (1973).
Ergotamine and methysergide abuse in patients with migraine. Br J Psychiatry 122:199-203.
Ludolph, A.C., I.W. Husstedt, H.P. Schlake, K.H. Grotemeyer, and G.G. Brune (1988).
Chronic ergotamine abuse: evidence of functional impairment of long ascending spinal tracts. Eur Neurol 28:311-316.
MacGregor, E.A., C. Vorah, and M. Wilkinson (1990).
Analgesic use: a study of treatments used by patients for migraine prior to attending the City of London migraine clinic. Headache 30:634-638.
Manzoni, G.C., G. Micieli, F. Granella, G. Sandrini, C. Zanferrari, and G. Nappi (1988).
Therapeutic approach to drug abuse in headache patients. In Drug-induced headache, (H.C. Diener and M. Wilkinson, eds.) pp. 143-149. Springer-Verlag, Berlin.
Marks, V. (1981).
Reactive (rebound) hypoglycemia). In Hypoglycemia, (V. Marks and C.F. Rose, eds.) pp. 179-217. Blackwell, Oxford.
Mathew, N.T. (1987).
Amelioration of ergotamine withdrawal symptoms with naproxen. Headache 27:130-133.
Mathew, N.T., R. Kurman, and F. Perez (1990).
Drug induced refractory headache - clinical features and management. Headache 30:634-638.
Michultka, D.M., E.B. Blanchard, K.A. Appelbaum, J. Jaccard, and M.P. Dentinger (1989).
The refractory headache patient--2. High medication consumption (analgesic rebound) headache. Behav Res Ther 27:411-420.
Micieli, G., G.C. Manzoni, F. Granella, E. Martignoni, G. Malferrari, and G. Nappi (1988).
Clinical and epidemiological observations on drug abuse in headache patients. In Drug-Induced Headache, (H.C. Diener and M. Wilkinson, eds.) pp. 20-28. Springer-Verlag, Berlin.
Nicolodi, M., P.L. DelBianco, and F. Sicuteri (1997).
The way to serotonergic use and abuse in migraine. Int J Clin Pharmacol Res 17:79-84.
Page, H. (1981).
Rebound headache from ergotamine withdrawal. JAMA 246:719.
Peters, G. and B.T. Horton (1951).
Headache: with special reference to the excessive use of ergotamine preparations and withdrawal effects. Proc Mayo Clin 26:153-161.
Pini, L.A. and T. Trenti (1994).
Case report: does chronic use of sumatriptan induce dependence? Headache 34:600-601.
Pradalier, A., S. Dry, and J.F. Baron (1984).
Cephalée induite par l'abuse de tartrate d'ergotamine chez les migrainieux. Concours Méd 106:106-110.
Rahman, A., M. Segasothy, S.A. Samad, A. Zulfiqar, and M. Rani (1993).
Analgesic use and chronic renal disease in patients with headache. Headache 33:442-445.
Rapoport, A., P. Stang, D.L. Gutterman, R. Cady, H. Markley, R. Weeks, J. Saiers, and A.W. Fox (1996).
Analgesic rebound headache in clinical practice: data from a physician survey. Headache 36:14-19.
Rapoport, A.M. (1988a).
Analgesic rebound headache. Headache 28:662-665.
Rapoport, A.M. and R.E. Weeks (1988b).
Characteristics and treatment of analgesic rebound headache. In Drug-induced headache, (H.C. Diener and M. Wilkinson, eds.) pp. 162-167. Springer-Verlag, Berlin.
Roswell, A.R., C. Neylan, and M. Wilkinson (1973).
Ergotamine induced headache in migrainous patients. Headache 13:65-67.
Sandler, D.P., J.C. Smith, C.R. Weinberg, V.M. Buckalew, V.W. Dennis, W.B. Blythe, and W.P. Burgess (1989).
Analgesic use and chronic renal disease. N Engl J Med 320:1238-1243.
Saper, J.R. (1983a).
Drug abuse among headache patients. In Headache disorders, (J.R. Saper, ed.) pp. 263-278. PSG Publishers, Boston.
Saper, J.R. (1983b).
Drug overuse among patients with headache. Neurol Clin 1:465-477.
Saper, J.R. (1990).
Daily chronic headaches. Neurol Clin N Amer 8:891-902.
Saper, J.R. and J.M. Jones (1986).
Ergotamine tartrate dependency: features and possible mechanisms. Clin Neuropharmacol 9:244-256.
Schnider, P., S. Aull, C. Baumgartner, and et al. (1996).
Long-term outcome of patients with headache and drug abuse after inpatient withdrawal: five-year followup. Cephalalgia 16:481-485.
Schnider, P., S. Aull, and M. Feucht (1994).
Use and abuse of analgesics in tension-type headache. Cephalalgia 14:162-167.
Schnider, P., J. Maly, J. Grunberger, S. Aull, K. Zeiler, and P. Wessely (1995).
Improvement of decreased critical flicker frequency in headache patients with drug abuse after successful withdrawal. Headache 35:269-272.
Schoenen, J., P. Lenarduzzi, and J. Sianard-Gainko (1989).
Chronic headaches associated with analgesics and/or ergotamine abuse: a clinical survey of 434 consecutive outpatients. In New advances in headache research, (F.D. Rose, ed.) pp. 29-43. Smith-Gordon, London.
Seller, E.M., U.E. Busto, H.L. Kaplan, G. Somer, and G.J. Baylon (1998).
Comparative abuse liability of codeine and naratriptan. Clin Pharmacol Ther 63:121.
Shakir, R.A. (1995).
Vitamin toxicity. In Handbook of clinical neurology, vol. 65 (F.A. DeWolff, ed.). New York: Elsevier Science: 567-576.
Silberstein, S.D. and R.B. Lipton (1997).
Chronic daily headache. In Headache, (P.J. Goadsby and S.D. Silberstein, eds.) pp. 201-225. Butterworth-Heinemann, Newton.
Silberstein, S.D., R.B. Lipton, S. Solomon, and N.T. Mathew (1994).
Classification of daily and near daily headaches: proposed revisions to the IHS classification. Headache 34:1-7.
Silberstein, S.D. and J.R. Silberstein (1992).
Chronic daily headache: prognosis following inpatient treatment with repetitive IV DHE. Headache 32:439-445.
Stewart, J.H. (1978).
Analgesic abuse and renal failure in Australia. Kidney Internat'l 13:72-78.
Sullivan, J.T. and E.M. Sellers (1986).
Treatment of the barbiturate abstinence syndrome. Med J Aust 145:456-458.
Taschner, K.L. and G.A. Wiesbeck (1988).
Psychiatric aspects of drug addiction of the barbiturate-alcohol type. In Drug-induced headache, (H.C. Diener and M. Wilkinson, eds.) pp. 80-84. Berlin, Springer-Verlag.
Tfelt-Hansen, P. (1985).
Ergotamine headache. In Updating in headache, (V. Pfaffenrath, P. Lundberg, and O. Sjaastad, eds.) pp. 169-172. Springer, Berlin.
Tfelt-Hansen, P. (1986).
The effect of ergotamine on the arterial system in man. Acta Pharmacol Toxicol 59:1-29.
Tfelt-Hansen, P. and A.A. Krabbe (1981a).
Ergotamine. Do patients benefit from withdrawal? Cephalalgia 1:29-32.
Tfelt-Hansen, P. and J. Olesen (1981b).
Arterial response to ergotamine tartrate in abusing and non-abusing migraine patients. Acta Physiol Scand 48:69-72.
Tfelt-Hansen, P. and L. Paalzow (1985).
Intramuscular ergotamine: plasma levels and dynamic activity. Clin Pharmacol Ther 37:29-35.
Tfelt-Hansen, P., P.R. Saxena, and M.D. Ferrari (1995).
Ergot alkaloids. In Handbook of clinical neurology, (F.A. DeWolff, ed.) pp. 61-67. New York: Elsevier Science.
Timmings, P.L. and A. Richens (1995).
Neurotoxicology of antiepileptic drugs. In Handbook of clinical neurology, (F.A. DeWolff, ed.) pp. 495-513. New York: Elsevier Science.
Vasconcellos, E., J.E. Pina-Garza, E.J. Millan, and J.S. Warner (1998).
Analgesic rebound headache in children and adolescents. J Child Neurol 13:443-447.
Verhoeff, N.P., W.H. Visser, M.D. Ferrari, P.R. Saxena, and E.A. vonRoyen (1993).
Dopamine D2 receptor imaging with 123-I-iodobenzamide SPECT in migraine patients abusing ergotamine: does ergotamine cross the blood brain barrier. Cephalalgia 13:325-329.
VonKorff, M., B.S. Galer, and P. Stang (1995).
Chronic use of symptomatic headache medications. Pain 62:179-186.
Walker, J., S. Parisi, and D. Olive (1993).
Analgesic rebound headache: experience in a community hospital. Southern Med J 86:1202-1205.
Warner, J.S. (1999).
Rebound headaches: a review. Headache Quarterly 10:207-219.
Zed, P.J., P.S. Loewen, and G. Robinson (1999).
Medication-induced headache: overview and systematic review of therapeutic approaches. Ann Pharmacother 33:61-72.
Ziegler, D.K. (2000).
Opiate and opioid use in patients with refractory headache. Cephalalgia 14:5-10.
8.3 Headache as an adverse event attributed to chronic medication
de Lignières B, Silberstein SD.
Pharmacodynamics of oestrogens and progestagens. Cephalalgia 2000;20:200-207.
Silberstein SD.
Hormone-related headache. M Clin N Am 2001;85:1017-1035.
Silberstein SD, de Lignières B.
Migraine, menopause and hormonal replacement therapy. Cephalalgia 2000;20:214-212.
8.4 Headache attributed to substance withdrawal
Abbott, P.J. (1986).
Caffeine: a toxicological overview. Med J Aust 145:518-521.
Baumgartner, G.R. and R.C. Rowen (1991).
Transdermal clonidine versus chlordiazepoxide in alcohol withdrawal: a randomized, controlled clinical trial. South Med J 84:312-321.
Dalessio, D.J. (1980).
Wolff's headache and other head pain, Oxford University Press, Oxford.
Epstein MT, JM Hockaday, TDR Hockaday (1975)
Migraine and reproductive hormones through the menstrual cycle. Lancet i:543-548.
Greden, J.F., M. Fontaine, M. Lubetsky, and K. Chamberlin (1978).
Anxiety and depression associated with caffeinism among psychiatric inpatients. Am J Psychiatr 135:963-966.
Laska, E.M., A. Sunshine, F. Mueller, W.B. Elvers, C. Siegel, and A. Rubin (1984).
Caffeine as an analgesic adjuvant. JAMA 251:1711-1718.
Lichten E, J Lichten, A Whitty, D Pieper (1996).
The confirmation of a biochemical marker for women's hormonal migraine : the depo-oestradiol challenge test. Headache 36: 367-71.
Raskin, N.H. and O. Appenzeller (1980).
Headache, Saunders, Philadelphia.
Silverman, K., S.M. Evans, E.C. Strain, and R.R. Griffiths (1992).
Withdrawal syndrome after the double-blind cessation of caffeine consumption. N Eng J Med 327:1109-1114.
Somerville B (1975).
Estrogen withdrawal migraine. Neurology 25: 239-250.
vanDusseldorp, M. and M.B. Katan (1990).
Headache caused by caffeine withdrawal among moderate coffee drinkers switched from ordinary to decaffeinated coffee: a 12 week double blind trial. Br Med J 300:1558-1559.
White, B.C., C.A. Lincoln, N.W. Pearcz, R. Reeb, and C. Vaida (1980).
Anxiety and muscle tension as consequence of caffeine withdrawal. Science 209:1547-1548.
